IP Verse

Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other Cancers

Patent No. EP3236985 (titled "Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other Cancers") was filed by Immatics Biotechnologies on Dec 16, 2015. The application was issued on Sep 7, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ADAPTIMMUNEJun 25, 2020MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3236985

IMMATICS BIOTECHNOLOGIES
Application Number
EP15813809A
Filing Date
Dec 16, 2015
Status
Patent Maintained As Amended
Aug 5, 2022
Publication Date
Sep 7, 2022
External Links
Slate, Register , Google Patents